eXTReMe Tracker

Latest Chikungunya Posts on ProMED-mail

  • PRO/EDR> Chikungunya (02): Americas, Africa
    Wed, 21 Apr 2021 16:09:41 -0400
    Chikungunya -- Worldwide/Unknown
    Saint-Herblain-based Valneva SE announced on 12 Apr 2021 that it had completed recruitment for the pivotal Phase 3 clinical trial of its single-shot chikungunya vaccine candidate, VLA1553.
    A total of 4131 adults aged 18 or above have been recruited across 44 sites in the USA for the VLA1553-301 trial, which was launched in September 2020. Participants will be followed for 6 months in the pivotal trial. If the trial results are positive, the trial is expected to support VLA1553's

Advertise on this site?

Statistics

Users
88
Articles
37
Articles View Hits
788677

Who is Online

We have 18 guests and no members online